Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 632 participants.

Also called NCT07180472

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 632 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07180472
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07180472. Randomized; no masking; primary purpose treatment. Start 2025-09-20 (anticipated); primary completion 2027-09-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol
Condition
Cerebral Small Vessel Disease
Intervention (Drug)
Cilostazol
Intervention (Drug)
Aspirin
Intervention (Drug)
Clopidogrel
Lead sponsor
First Affiliated Hospital of Chengdu Medical College (class: other)

Record details

Record id
cardio:ct-nct07180472
Content hash
09fd1a77fcf65d8cb9e8155033c575705079a99bb051baf6e6d205c2027684a9